Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -174.34%-6.35M | 186.95%4.67M | 74.15%-531K | -367.33%-7.58M | -228.01%-2.92M | -151.43%-2.32M | -276.61%-5.37M | -396.14%-2.05M | 233.30%2.83M | -43.04%2.28M |
| Net profit before non-cash adjustment | 9.68%-16.05M | 76.88%-4.36M | -4,692.98%-5.24M | -305.55%-3.52M | -306.09%-2.94M | 24.53%-17.77M | 20.29%-18.88M | -99.24%114K | 111.38%1.71M | -488.71%-723K |
| Total adjustment of non-cash items | -22.44%5.4M | -63.84%1.3M | 59.40%1.81M | 8.19%1.53M | -7.62%764K | -64.60%6.96M | -81.22%3.58M | 107.48%1.13M | -90.60%1.42M | 25.88%827K |
| -Depreciation and amortization | 32.01%2.99M | 96.96%778K | 12.69%755K | 7.51%730K | 39.54%727K | -17.77%2.27M | -82.66%395K | 1,440.00%670K | 207.24%679K | 70.82%521K |
| -Reversal of impairment losses recognized in profit and loss | --0 | ---- | ---- | ---- | ---- | 671.41%3.02M | ---- | ---- | ---- | ---- |
| -Assets reserve and write-off | -219.85%-495K | --0 | --0 | --0 | ---495K | -97.34%413K | ---43K | --0 | -96.97%456K | --0 |
| -Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Net exchange gains and losses | 273.44%239K | 48.78%61K | --68K | 157.14%24K | 32.31%86K | 203.63%64K | -60.22%41K | --0 | 82.13%-42K | -75.93%65K |
| -Other non-cash items | 121.63%2.66M | 161.14%457K | 112.31%983K | 140.87%778K | 85.06%446K | 20.67%1.2M | -78.58%175K | 392.55%463K | 10,666.67%323K | 193.90%241K |
| Changes in working capital | -58.56%4.3M | -34.43%7.74M | 187.82%2.9M | -1,808.19%-5.59M | -134.22%-744K | 23.80%10.39M | 54.63%11.81M | -1,174.52%-3.3M | 86.33%-293K | -31.12%2.17M |
| -Change in receivables | 141.55%1.43M | -60.12%4.05M | 128.04%1.24M | 70.87%-2.93M | -207.50%-932K | 18.82%-3.44M | 1,586.41%10.16M | -18.99%-4.41M | -365.49%-10.05M | -15.91%867K |
| -Change in inventory | -88.68%1.33M | -102.11%-129K | 274.23%1.91M | -126.01%-1.87M | 412.20%1.41M | 480.17%11.73M | 535.70%6.11M | 58.25%-1.1M | 109.68%7.17M | 81.76%-451K |
| -Change in payables | -26.06%1.55M | 185.61%3.82M | -111.36%-251K | -130.83%-798K | -169.40%-1.22M | -86.66%2.1M | -152.88%-4.46M | -63.66%2.21M | 176.05%2.59M | -61.76%1.76M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -12K | 0 | 0 | 0 | ||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 335,200.00%3.35M | 339,500.00%3.4M | -1,900.00%-20K | 1,766.67%1K | 1K | -1K | ||||
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -29.56%-3M | 250.19%8.07M | 73.19%-551K | -367.62%-7.59M | -228.53%-2.93M | -151.53%-2.31M | -267.31%-5.37M | -304.53%-2.06M | 233.16%2.84M | -41.84%2.28M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -162.60%-2.39M | -1,319.54%-1.24M | -431.85%-718K | 39.74%-414K | ---20K | 72.60%-909K | 91.02%-87K | -163.98%-135K | -748.11%-687K | --0 |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest received (cash flow from investment activities) | --0 | ---- | ---- | ---- | ---- | --1K | ---- | ---- | ---- | ---- |
| Investing cash flow | -162.89%-2.39M | -1,336.05%-1.24M | -431.85%-718K | 39.74%-414K | ---20K | 72.63%-908K | 91.13%-86K | -163.98%-135K | -748.11%-687K | --0 |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 14,882.61%10.2M | -550.86%-3.15M | 50.87%1.48M | 1,214.62%8.54M | 439.00%3.33M | 98.49%-69K | 113.51%698K | -62.15%981K | 65.57%-766K | -516.10%-982K |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --4.73M | ---- | ---- | ---- | ---- |
| Increase or decrease of lease financing | -1,265.33%-2.72M | -1,177.89%-2.54M | ---59K | ---58K | ---57K | -380.54%-199K | ---199K | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | -111.60%-2.66M | -96.98%-457K | -112.31%-983K | -140.87%-778K | -85.06%-446K | -27.74%-1.26M | 76.46%-232K | ---463K | ---323K | ---241K |
| Net other fund-raising expenses | 164.18%1.38M | --0 | --0 | 148,300.00%1.48M | -2,160.00%-103K | -32.72%522K | 48.89%518K | --0 | ---1K | -99.82%5K |
| Financing cash flow | 66.39%6.2M | -211.46%-6.15M | -15.44%438K | 942.57%9.18M | 323.56%2.72M | 177.36%3.73M | 194.33%5.52M | -82.85%518K | 78.22%-1.09M | -140.38%-1.22M |
| Net cash flow | ||||||||||
| Beginning cash position | 31.35%-1.29M | 18.85%-1.17M | -215.46%-336K | -70.67%-1.52M | 31.35%-1.29M | -220.88%-1.89M | -147.24%-1.44M | -90.29%291K | -115.28%-890K | -220.91%-1.89M |
| Current changes in cash | 61.63%813K | 1,103.51%686K | 50.30%-831K | 11.81%1.18M | -121.23%-225K | 113.81%503K | 101.58%57K | -161.40%-1.67M | 115.05%1.06M | -75.16%1.06M |
| Effect of exchange rate changes | --0 | ---- | ---- | --0 | --0 | -55.13%89K | -22.20%88.95K | -138.16%-58K | 280.88%123K | ---65K |
| Cash adjustments other than cash changes | ---1.32M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| End cash Position | -39.52%-1.8M | -39.52%-1.8M | 18.85%-1.17M | -215.46%-336K | -70.67%-1.52M | 31.41%-1.29M | 31.41%-1.29M | -147.24%-1.44M | -90.29%291K | -115.28%-890K |
| Free cash flow | -67.08%-5.39M | 225.17%6.83M | 42.05%-1.27M | -472.49%-8M | -229.41%-2.95M | -374.85%-3.22M | -343.53%-5.46M | -637.37%-2.19M | 206.18%2.15M | 82.09%2.28M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.